Javascript must be enabled to continue!
Chlorogenic acid alleviates the intestinal barrier dysfunction and intestinal flora disorder induced by cisplatin
View through CrossRef
Abstract
This article conducted research and analysis on the relationship between cisplatin induced intestinal barrier disruption, gut microbiota imbalance, and the protect effect of chlorogenic acid (CGA) on gastro intestine. This article selected C57BL/6J mice as the research object, with an age of 4 weeks and a total of 28 mice. The mice were divided into 4 groups, including the control group (CN), a cisplatin (Cis) group, a CGA treatment group receiving intraperitoneal injections alongside cisplatin (Cis + CGA1), and the last group pre-treated with CGA before cisplatin administration (Cis + CGA2). This study used RT qPCR to determine IL-6, IL-1β and TNF-ɑ mRNA, while serum levels of these cytokines and fecal LPS were determined through ELISA. Western blot was used to analyze the expression of Occludin and ZO-1 proteins in colon tissue, and H&E staining to study the histopathological conditions of the colon tissue. Moreover, this article also utilized high-throughput sequencing to analyze the gut microbiota of feces. The results indicated that CGA administration reduced IL-6, IL-1β and TNF-α level in both colon tissue and serum compared to the Cis group. CGA pretreatment notably enhanced the expression of Occludin and ZO-1 proteins in colon tissues, improved intestinal barrier integrity. Histopathological analysis confirmed the reduction in intestinal inflammation injury with CGA treatment. Moreover, 16S rDNA sequencing showed that while Bacteroidetes and Firmicutes predominated in the control group, the Cis group saw a rise in Proteobacteria, with a notable shift in the gut microbiota's composition and a decrease in α diversity. CGA treatment was able to mitigate these changes induced by cisplatin. All results suggest CGA effectively mitigates the inflammatory response and destruction of the mucosal barrier in the intestines caused by cisplatin, offering a protective effect against the disturbances of intestinal flora.
Springer Science and Business Media LLC
Title: Chlorogenic acid alleviates the intestinal barrier dysfunction and intestinal flora disorder induced by cisplatin
Description:
Abstract
This article conducted research and analysis on the relationship between cisplatin induced intestinal barrier disruption, gut microbiota imbalance, and the protect effect of chlorogenic acid (CGA) on gastro intestine.
This article selected C57BL/6J mice as the research object, with an age of 4 weeks and a total of 28 mice.
The mice were divided into 4 groups, including the control group (CN), a cisplatin (Cis) group, a CGA treatment group receiving intraperitoneal injections alongside cisplatin (Cis + CGA1), and the last group pre-treated with CGA before cisplatin administration (Cis + CGA2).
This study used RT qPCR to determine IL-6, IL-1β and TNF-ɑ mRNA, while serum levels of these cytokines and fecal LPS were determined through ELISA.
Western blot was used to analyze the expression of Occludin and ZO-1 proteins in colon tissue, and H&E staining to study the histopathological conditions of the colon tissue.
Moreover, this article also utilized high-throughput sequencing to analyze the gut microbiota of feces.
The results indicated that CGA administration reduced IL-6, IL-1β and TNF-α level in both colon tissue and serum compared to the Cis group.
CGA pretreatment notably enhanced the expression of Occludin and ZO-1 proteins in colon tissues, improved intestinal barrier integrity.
Histopathological analysis confirmed the reduction in intestinal inflammation injury with CGA treatment.
Moreover, 16S rDNA sequencing showed that while Bacteroidetes and Firmicutes predominated in the control group, the Cis group saw a rise in Proteobacteria, with a notable shift in the gut microbiota's composition and a decrease in α diversity.
CGA treatment was able to mitigate these changes induced by cisplatin.
All results suggest CGA effectively mitigates the inflammatory response and destruction of the mucosal barrier in the intestines caused by cisplatin, offering a protective effect against the disturbances of intestinal flora.
Related Results
RNA-seq analysis of chlorogenic acid intervention in duck embryo fibroblasts infected with duck plague virus
RNA-seq analysis of chlorogenic acid intervention in duck embryo fibroblasts infected with duck plague virus
Abstract
Introduction Chlorogenic acid is the main active ingredient of honeysuckle, with anti-inflammatory and antiviral effects. At present, duck plague virus causes a l...
Abstract 1761: Dual inhibition of HSP27 and FAO as a novel therapeutic strategy for cisplatin-resistant ovarian cancer
Abstract 1761: Dual inhibition of HSP27 and FAO as a novel therapeutic strategy for cisplatin-resistant ovarian cancer
Abstract
Cisplatin is the most commonly employed chemotherapeutic drug for ovarian cancer treatment. However, most ovarian cancer patients experience recurrent cispl...
Abstract 1490: RAD51C-deficient cancer cells require DNA polymerase zeta to bypass cisplatin-induced lesion
Abstract 1490: RAD51C-deficient cancer cells require DNA polymerase zeta to bypass cisplatin-induced lesion
RAD51C is a RAD51 paralog protein that mediates RAD51 filament formation on single-stranded DNA (ssDNA) in a canonical homologous recombination (HR) pathway. This step is vital for...
RNA-seq analysis of chlorogenic acid intervention in duck embryo fibroblasts infected with duck plague virus
RNA-seq analysis of chlorogenic acid intervention in duck embryo fibroblasts infected with duck plague virus
Abstract
Introduction
Chlorogenic acid, the primary active component in Chinese medicines like honeysuckle, exhibits anti-inflammatory and antiviral...
Astrocytes improve neuronal health after cisplatin treatment through mitochondrial transfer
Astrocytes improve neuronal health after cisplatin treatment through mitochondrial transfer
AbstractNeurodegenerative disorders, including chemotherapy-induced cognitive impairment, are associated with neuronal mitochondrial dysfunction. Cisplatin, a commonly used chemoth...
Abstract 2271: Autophagy induction by low dose cisplatin: The role of p53 in autophagy
Abstract 2271: Autophagy induction by low dose cisplatin: The role of p53 in autophagy
Abstract
Cisplatin has been mainly used for lung-cancer. However, cisplatin has many side effects, so the usage of cisplatin has a limitation. Recently, autophagy ha...
Data from Disrupting Protein NEDDylation with MLN4924 Is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer
Data from Disrupting Protein NEDDylation with MLN4924 Is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer
<div>Abstract<p><b>Purpose:</b> Ovarian cancer has the highest mortality rate of all female reproductive malignancies. Drug resistance is a major cause of t...

